Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Similar articles for PubMed (Select 20143946)

1.

Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.

Moutaftsi M, Tscharke DC, Vaughan K, Koelle DM, Stern L, Calvo-Calle M, Ennis F, Terajima M, Sutter G, Crotty S, Drexler I, Franchini G, Yewdell JW, Head SR, Blum J, Peters B, Sette A.

Future Microbiol. 2010 Feb;5(2):221-39. doi: 10.2217/fmb.09.110. Review.

2.

Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens.

Sette A, Grey H, Oseroff C, Peters B, Moutaftsi M, Crotty S, Assarsson E, Greenbaum J, Kim Y, Kolla R, Tscharke D, Koelle D, Johnson RP, Blum J, Head S, Sidney J.

Vaccine. 2009 Dec 30;27 Suppl 6:G21-6. doi: 10.1016/j.vaccine.2009.10.011. Review.

3.

CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.

Fang M, Remakus S, Roscoe F, Ma X, Sigal LJ.

J Virol. 2015 Jan;89(1):776-83. doi: 10.1128/JVI.02176-14. Epub 2014 Oct 29.

PMID:
25355885
4.

Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities.

Sette A, Moutaftsi M, Moyron-Quiroz J, McCausland MM, Davies DH, Johnston RJ, Peters B, Rafii-El-Idrissi Benhnia M, Hoffmann J, Su HP, Singh K, Garboczi DN, Head S, Grey H, Felgner PL, Crotty S.

Immunity. 2008 Jun;28(6):847-58. doi: 10.1016/j.immuni.2008.04.018.

5.

Vaccinia virus-specific CD4+ T cell responses target a set of antigens largely distinct from those targeted by CD8+ T cell responses.

Moutaftsi M, Bui HH, Peters B, Sidney J, Salek-Ardakani S, Oseroff C, Pasquetto V, Crotty S, Croft M, Lefkowitz EJ, Grey H, Sette A.

J Immunol. 2007 Jun 1;178(11):6814-20.

6.

Immune modulation in primary vaccinia virus zoonotic human infections.

Silva Gomes JA, de Araújo FF, de Souza Trindade G, Quinan BR, Drumond BP, Ferreira JM, Mota BE, Nogueira ML, Kroon EG, Santos Abrahão J, Côrrea-Oliveira R, da Fonseca FG.

Clin Dev Immunol. 2012;2012:974067. doi: 10.1155/2012/974067. Epub 2011 Dec 20.

7.

Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.

Garber DA, O'Mara LA, Zhao J, Gangadhara S, An I, Feinberg MB.

PLoS One. 2009;4(5):e5445. doi: 10.1371/journal.pone.0005445. Epub 2009 May 6.

8.

Human T-cell responses to vaccinia virus envelope proteins.

Tang J, Murtadha M, Schnell M, Eisenlohr LC, Hooper J, Flomenberg P.

J Virol. 2006 Oct;80(20):10010-20.

9.

Analysis of A47, an immunoprevalent protein of vaccinia virus, leads to a reevaluation of the total antiviral CD8+ T cell response.

Yuen TJ, Flesch IE, Hollett NA, Dobson BM, Russell TA, Fahrer AM, Tscharke DC.

J Virol. 2010 Oct;84(19):10220-9. doi: 10.1128/JVI.01281-10. Epub 2010 Jul 28.

10.

Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus.

Meng X, Zhong Y, Embry A, Yan B, Lu S, Zhong G, Xiang Y.

Virology. 2011 Jan 20;409(2):271-9. doi: 10.1016/j.virol.2010.10.019. Epub 2010 Nov 5.

11.

Intradermal immune response after infection with Vaccinia virus.

Jacobs N, Chen RA, Gubser C, Najarro P, Smith GL.

J Gen Virol. 2006 May;87(Pt 5):1157-61.

12.

Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.

Terajima M, Orphin L, Leporati AM, Pazoles P, Cruz J, Rothman AL, Ennis FA.

Hum Immunol. 2008 Dec;69(12):815-25. doi: 10.1016/j.humimm.2008.09.009. Epub 2008 Oct 26. Erratum in: Hum Immunol. 2009 Mar;70(3):210.

13.

GM-CSF production allows the identification of immunoprevalent antigens recognized by human CD4+ T cells following smallpox vaccination.

Judkowski V, Bunying A, Ge F, Appel JR, Law K, Sharma A, Raja-Gabaglia C, Norori P, Santos RG, Giulianotti MA, Slifka MK, Douek DC, Graham BS, Pinilla C.

PLoS One. 2011;6(9):e24091. doi: 10.1371/journal.pone.0024091. Epub 2011 Sep 9.

14.

Adverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virus.

Mota BE, Gallardo-Romero N, Trindade G, Keckler MS, Karem K, Carroll D, Campos MA, Vieira LQ, da Fonseca FG, Ferreira PC, Bonjardim CA, Damon IK, Kroon EG.

PLoS One. 2011 Apr 15;6(4):e18924. doi: 10.1371/journal.pone.0018924.

15.

Correlations between vaccinia-specific immune responses within a cohort of armed forces members.

Umlauf BJ, Ovsyannikova IG, Haralambieva IH, Kennedy RB, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA.

Viral Immunol. 2011 Oct;24(5):415-20. doi: 10.1089/vim.2011.0029. Epub 2011 Sep 29.

16.

Capturing the natural diversity of the human antibody response against vaccinia virus.

Lantto J, Haahr Hansen M, Rasmussen SK, Steinaa L, Poulsen TR, Duggan J, Dennis M, Naylor I, Easterbrook L, Bregenholt S, Haurum J, Jensen A.

J Virol. 2011 Feb;85(4):1820-33. doi: 10.1128/JVI.02127-10. Epub 2010 Dec 8.

17.

Immunodomination during peripheral vaccinia virus infection.

Lin LC, Flesch IE, Tscharke DC.

PLoS Pathog. 2013;9(4):e1003329. doi: 10.1371/journal.ppat.1003329. Epub 2013 Apr 25.

18.

An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling.

Jing L, Davies DH, Chong TM, Chun S, McClurkan CL, Huang J, Story BT, Molina DM, Hirst S, Felgner PL, Koelle DM.

J Virol. 2008 Jul;82(14):7120-34. doi: 10.1128/JVI.00453-08. Epub 2008 May 14. Erratum in: J Virol. 2009 Mar;83(5):2404.

19.

T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.

Davies DH, Chun S, Hermanson G, Tucker JA, Jain A, Nakajima R, Pablo J, Felgner PL, Liang X.

J Immunol. 2014 Aug 15;193(4):1812-27. doi: 10.4049/jimmunol.1400663. Epub 2014 Jul 14.

PMID:
25024392
20.

Human cytotoxic T-cell memory: long-lived responses to vaccinia virus.

Demkowicz WE Jr, Littaua RA, Wang J, Ennis FA.

J Virol. 1996 Apr;70(4):2627-31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk